The global Nifedipine market size is predicted to grow from US$ 1228 million in 2025 to US$ 1970 million in 2031; it is expected to grow at a CAGR of 8.2% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries.

The nifedipine market based on geography can be further segmented into North America, Europe, Asia Pacific, South America, and Rest of the World. North America will account for the largest share in 2022. The growth of this segment is due to factors such as widespread obesity among the American public leading to increased ailments such as heart disease, angina, hypertension, etc. In 2021, the United States leads every other country on earth in obesity rates. Approximately 36.20% of adults in the United States face overweight issues, which leads the calcium channel blocker drugs market.

However, Asia Pacific is expected to be the fastest growing segment. This growth is due to the increasing elderly population, especially in countries like India and China, the rise in chronic diseases, and the continuous improvement of medical infrastructure as governments allocate countless funds for development.

Infinity Market Research newest research report, the Nifedipine Industry Forecast looks at past sales and reviews total world Nifedipine sales in 2024, providing a comprehensive analysis by region and market sector of projected Nifedipine sales for 2025 through 2031. With Nifedipine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nifedipine industry.

This Insight Report provides a comprehensive analysis of the global Nifedipine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nifedipine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Nifedipine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nifedipine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nifedipine.

This report presents a comprehensive overview, market shares, and growth opportunities of Nifedipine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Nifedipine Controlled Release Tablets
    Nifedipine Extended Action Tablets

Segmentation by Application:

    Hypertension
    Heart Disease
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Bayer
    Actavis
    Teva
    Pfizer
    Shyndec
    Honglin Pharmaceutical
    Huanghai
    Yabao
    Lifeon Pharmaceutical
    EASEHEAL Pharmaceutical
    ApicHope
    Simcere

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nifedipine market?
What factors are driving Nifedipine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nifedipine market opportunities vary by end market size?
How does Nifedipine break out by Type, by Application?